Author: admin

  • Michelle Donelan – 2015 Parliamentary Question to the Department of Health

    Michelle Donelan – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Michelle Donelan on 2015-10-22.

    To ask the Secretary of State for Health, what steps he plans to take to encourage more people to join healthcare professions in rural areas experiencing difficulties with staff recruitment.

    Ben Gummer

    Health Education England was established to deliver a better healthcare workforce for England and is accountable for ensuring a secure workforce supply for the future. It ensures that the workforce has the right skills, behaviours and training, and is available in the right numbers, to support the delivery of excellent healthcare and drive improvements.

    National Health Service organisations are best placed to decide how many staff they employ. Services should be tailored to meet the needs of their patients and local communities, to deliver safe care.

  • Alan Campbell – 2015 Parliamentary Question to the Department of Health

    Alan Campbell – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Alan Campbell on 2015-10-22.

    To ask the Secretary of State for Health, whether the North Tyneside Clinical Commissioning Group is a pilot under the General Practitioners’ Referral Management System.

    Ben Gummer

    NHS North Tyneside Clinical Commissioning Group (CCG) has introduced a formal referral management system across a small number of clinical specialties. This is a local initiative and not part of a wider scheme. The data requested are not collected centrally. This is a matter for the North Tyneside CCG who can advise on data availability.

  • Alan Campbell – 2015 Parliamentary Question to the Department of Health

    Alan Campbell – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Alan Campbell on 2015-10-22.

    To ask the Secretary of State for Health, how much is paid to the About Health Group for each patient referred by practices in the North Tyneside Clinical Commissioning Group under the General Practitioners’ Referral Management System.

    Ben Gummer

    NHS North Tyneside Clinical Commissioning Group (CCG) has introduced a formal referral management system across a small number of clinical specialties. This is a local initiative and not part of a wider scheme. The data requested are not collected centrally. This is a matter for the North Tyneside CCG who can advise on data availability.

  • Kate Osamor – 2015 Parliamentary Question to the Department of Health

    Kate Osamor – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Kate Osamor on 2015-10-22.

    To ask the Secretary of State for Health, what his policy is on the provision by the NHS of free IVF to women whose partners have had immigration applications rejected.

    Jane Ellison

    The provision of in-vitro fertilisation services is a matter for clinical commissioning groups, in compliance with the National Health Service (Charges to Overseas Visitors) Regulations 2015, and with regard to the National Institute for Health and Care Excellence guidelines on fertility services.

  • Alex Cunningham – 2015 Parliamentary Question to the Department of Health

    Alex Cunningham – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Alex Cunningham on 2015-10-22.

    To ask the Secretary of State for Health, what assessment his Department has made of the findings of the Carers Trust report published on 16 September 2015, Analysis of the UK and Impact of Charges by Councils Providing Support to Unpaid Carers; and if he will make an assessment of the effect of local authority charges on carers for the support they receive to help them in their caring role.

    Alistair Burt

    The Department has been clear that local authorities are not required to charge a carer for support and indeed in many cases it would be a false economy to do so.

    We have produced a suite of implementation support documents around the new carers’ rights, one of which is The Economic Case for Investment in Carers, a short factsheet for local authorities to use in considering whether to put in place a policy of charging carers, setting out the evidence that charging would be a false economy. This expands on the position set out in the Care Act statutory guidance, which at paragraph 8.50 states that:

    “Local authorities are not required to charge a carer for support and indeed in many cases it would be a false economy to do so. When deciding whether to charge, and in determining what an appropriate charge is, a local authority should consider how it wishes to express the way it values carers within its local community as partners in care, and recognise the significant contribution carers make.”

    The Care Act replicates the previous position where charging carers was permissible. It would not have been appropriate to impose a blanket ban on charging for carers services, because in some cases small charges are necessary to the viability of services. However, the Care Act provides additional protection to carers by making it clear that local authorities cannot charge carers for services provided to the person being cared for. This means that carers may only be charged for services provided directly to them.

    Most local authorities do not routinely charge carers in recognition of the valuable contribution carers make to their local communities, and the Carers Trust report confirms that this is still the case. We will continue to make the case against routine charging of carers and to monitor the situation closely through the implementation monitoring process set out below.

    To support implementation of the reform programme, we have established a joint Programme Management Office between the Department, Local Government Association and Association of Directors of Adults Social Services. This unprecedented partnership is driving collaborative working with the sector, influencing the local implementation of these changes to support a consistent and coherent approach. This approach was recognised by the National Audit Office as best practice and should be adopted by other programmes.

    The programme includes a series of stocktakes of local authority readiness and the latest, from June 2015, demonstrates an overall positive picture on implementation:

    – Councils’ confidence in their ability to deliver the Care Act Reforms in 2015/16 remains high, with 99% very or fairly confident.

    – 89% of councils say that they are ‘on track’ with their implementation. The remaining 11% report themselves as only slightly behind.

  • Laurence Robertson – 2015 Parliamentary Question to the Department of Health

    Laurence Robertson – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Laurence Robertson on 2015-10-22.

    To ask the Secretary of State for Health, pursuant to the Answer of 21 October 2015 to Question 12247, on breast cancer, what assessment his Department has made of the 26 recommendations produced by charities on access to off-patent, repurposed drugs following the roundtable event of February 2015.

    George Freeman

    The Government hosted a Roundtable Event to explore the issues around off-label prescribing as part of its response to a Private Member’s Bill presented in the last Parliament. The Government’s position on the current Off Patent Drugs Bill and how that relates to issues identified at the Roundtable Event will be shared at the Bill’s second reading on 6 November 2015.

  • Gerald Howarth – 2015 Parliamentary Question to the Department of Health

    Gerald Howarth – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Gerald Howarth on 2015-10-22.

    To ask the Secretary of State for Health, whether Monitor plans to create a new maternity tariff for multiple pregnancies which more closely meets the costs associated with delivering the best practice care pathways outlined by NICE and the Royal College of Obstetricians and Gynaecologists; and if he will make a statement.

    Ben Gummer

    Monitor and NHS England are working with providers on a bottom-up costing exercise for maternity services.Returns are due in mid-November and analysis over the following couple of months will help to ensure that the tariffs are improved to more closely reflect the costs of service delivery. This will help inform prices for 2017/18.

  • Greg Mulholland – 2015 Parliamentary Question to the Department of Health

    Greg Mulholland – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Greg Mulholland on 2015-10-22.

    To ask the Secretary of State for Health, pursuant to the Answer of 16 October 2015 to Question 11322, on NHS training, for what reasons the materials were withdrawn from the Library.

    Jane Ellison

    Due to an administrative error, the wrong documents were placed in the Library. We are looking into this as a matter of urgency and an update will be provided to the hon. Member as soon as possible.

  • Gerald Howarth – 2015 Parliamentary Question to the Department of Health

    Gerald Howarth – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Gerald Howarth on 2015-10-22.

    To ask the Secretary of State for Health, whether he plans for his Department’s Innovation, Excellence and Strategic Development Fund to be used to support efforts to reduce still births and neonatal deaths in multiple pregnancies.

    Ben Gummer

    There are no specific plans for the Innovation, Excellence and Strategic Development (IESD) fund to support efforts to reduce still births and neonatal deaths in multiple pregnancies. The IESD fund provides for funding for voluntary sector projects that are able to demonstrate a clear focus on supporting and driving forward new ideas, excellence or the undertaking of strategic developments in voluntary sector capacity and capability in health and care.

    The fund does not have a particular focus on reducing still births and neonatal deaths in multiple pregnancies, but aims to support projects with the potential to have national significance in any area of health and care, particularly where statutory services can be complemented and high quality health and care outcomes achieved.

  • Jim Cunningham – 2015 Parliamentary Question to the Department of Health

    Jim Cunningham – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Cunningham on 2015-10-22.

    To ask the Secretary of State for Health, what assessment his Department has made of trends in the diagnosis levels of inflammatory bowel diseases in England and Wales; and if he will make a statement.

    Jane Ellison

    The two main forms of inflammatory bowel disease (IBD) are Crohn’s disease and ulcerative colitis. Ulcerative colitis only affects the large intestine whereas Crohn’s disease affects the whole of the digestive system.

    The National Institute for Health and Care Excellence (NICE) guidance indicates that ulcerative colitis has an incidence in the United Kingdom of approximately 10 per 100,000 people annually, and a prevalence of approximately 240 per 100,000. This amounts to around 146,000 people in the UK with a diagnosis of ulcerative colitis. In addition to this, there are currently at least 115,000 people in the UK with Crohn’s disease.

    The Department does not hold information on diagnosis levels in Wales specifically; this is a matter for the devolved administration.

    NICE published Crohn’s Disease Management in Adults, Children and Young People in October 2012 and Ulcerative Colitis Management in Adults, Children and Young People in June 2013. These set out best practice in the management of these conditions.

    Treatment for both Crohn’s disease and ulcerative colitis is largely directed at symptom relief to improve quality of life, rather than cure. Management options include drug therapy, dietary and lifestyle advice and, in severe or chronic active disease, surgery. The aims of drug treatment are to reduce symptoms and maintain or improve quality of life.